Shionogi Lays Out R&D Goals Ahead of Crestor Challenges

Japan's Shionogi is looking to bolster its presence in core therapeutic areas, unveiling positive new data for a novel constipation therapy and a raft of anti-infective projects at a recent R&D update.

More from Alimentary/Metabolic

More from Therapy Areas